WallStreetZenWallStreetZen

AnalystsStephen Brozak
Stephen Brozak's Stock Forecasts

Sectors:
Healthcare
Industries:
Biotechnology
Analyst Ranking
Top 38%
#1877 out of 4929 analysts
Average Return
+70.61%
Win Rate
100%3 out of 3
Risk vs Reward
Poor
Good

Stephen Brozak's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Cidara Therapeutics IncCDTX
+144.76%$19.93$48.78
2024-12-05 -
2025-07-03
Strong Buy
Paratek Pharmaceuticals IncPRTK
+51.32%$4.17$6.31
2020-01-08 -
2021-01-08
Buy
Cidara Therapeutics IncCDTX
+15.75%$146.00$123.00
2017-07-28 -
2017-08-11
Sell

Stephen Brozak Analyst Color

Get additional color on Stephen Brozak's coverage of popular stocks

Stephen Brozak's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Cidara Therapeutics IncCDTX
4Strong Buy$45.00-7.75%Maintains
7 months ago
Arcturus Therapeutics Holdings IncARCT
1Hold$31.00N/ADowngrades
5 years ago
Paratek Pharmaceuticals IncPRTK
1Buy$6.00N/AInitiates Coverage On
5 years ago
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.